期刊文献+

基于抗原-抗体共表达的细菌展示技术的优化

Optimization of bacterial display technology based on antigen-antibody co-expression
下载PDF
导出
摘要 目的建立细菌周质内抗原抗体共表达系统。方法将人白介素-1β(hIL-1β)基因和抗人白介素1β单链抗体(anti-hIL-1βscFv)基因分别插入到细菌展示载体pBFD的pelB前导肽(游离型前导肽)和NlpA前导肽(锚定型前导肽)下游构建出重组载体pBFD-Ab-Ag。将pBFD-Ab-Ag转入到E.coli DH5α中诱导表达,抗原和抗体蛋白相互结合而被锚定到细菌内膜外侧,破除细菌外壁(原生质球制备)后与适当浓度的FITC标记的小鼠抗hIL-1β抗体进行孵育,最后经流式细胞仪检测荧光信号,根据荧光信号强弱分析抗原抗体表达和相互作用情况。结果 pBFD-Ab-Ag E.coli DH5α具有很强的荧光信号,阳性率获得了大大的提高。结论成功建立了建立细菌周质内抗原抗体共表达系统,实现了抗体和抗原细菌周质内的正确折叠和相互识别。简化了现有的抗体筛选的流程,为蛋白质相互作用的研究提供了新的技术手段。 Objective To co-express antigen and antibody in E. coli periplasm in which the antigen and antibody will fold correctly and bind to each other. Methods Human IL-1β gone and mouse anti-human IL-1α single chain variable fragment (anti-hlL-1β scFv) were inserted into the down stream from the NIpA and pelB leading peptides of pBFD vector respectively. The recombinant plasmid was named pBFD-Ab-Ag. The E. coli DH5α transformed with pBFD-Ab-Ag was induced by IPTG to co-express antigen and antibody. After the outer membrane of E. coli DH5αwas broken (spheroplast formation), the bacteria were incubated with mouse anti-hlL-1βantibody labeled by FITC. The co-expression and interaction of antigen and antibody was analyzed by flow cytometry (FCM) based on fluorescence signal intensity. Results The FCM detection showed the strong signal in E. coli DHSα transformed with pBFD-Ab-Ag and the positive rate was significantly improved. Conclusion The results showed that the antigen and antibody can fold and bind to each other efficiently in E. coli periplasm. The system can make antibody screening process easier and also provide a novel method for protein-protein interaction.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2013年第4期396-399,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(31001084 30700591)
关键词 周质空间 抗原抗体共表达 流式细胞仪筛选 抗体库筛选 蛋白相互作用 periplasm antigen-antibody co-expression FCM screening antibody library screening protein-protein interaction
  • 相关文献

参考文献15

  • 1Hoogenboom HR. Selecting and screening recombinant antibody libraries [J]. Nat Biotechnol, 2005, 23(9) : 1105 -1116.
  • 2徐黎明,尹成凯,任桂萍,田辉,王雪琴,丁良君,李德山.筛选Fab抗体库的细菌展示技术的建立[J].细胞与分子免疫学杂志,2011,27(10):1090-1093. 被引量:7
  • 3Jeong KJ, Seo MJ, lverson BL, et al. APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and englneer- ing[J]. Proc Nail Acad Sci USA, 2007, 104(20) : 8247 -8252.
  • 4Harvey BR, Georgiou G, Hayhurst A, et al. Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries [ J ]. Proc Nail Acad Sci USA, 2004, 101 (25) : 9193 -9198.
  • 5Harvey BR, Shanafelt AB, Baburina I, et al. Engineering of recom- binant antibody fragments to methamphetamine by anchored periplas- mic expression[ J]. J Immunol Methods, 2006, 308 ( 1 - 2 ) : 43 - 52.
  • 6MSssner E, Huber-Wunderlich M, Glockshuber R. Characterization of Escherichia coli thioredoxin variants mimicking the active-sites of other thiol/disulfide oxidoreductases[ J]. Protein Sci, 1998, 7 (5) : 1233 - 1244.
  • 7Batisson I, Vartanian MD. Extracellular Dsb Ainsensitive folding of Escherichia coli heat-stable enterotoxin STa in vitro [ J ]. J Biol Chem, 2000, 275( 14): 10582-10589.
  • 8Raina S, Missiakas D. Making and breaking disulfide bonds [ J]. Annu Rev Microbiol, 1997, 51:179 -202.
  • 9Phamle TM, Kim S J, Song BK, et al. Optimized refolding and char- acterization of S-peroxidase ( CWPO_C of Populus alba) expressed in E. coli[J]. Protein Expr Purif, 2011, 80(2) : 268 -273.
  • 10Scboner BE, Belagaje RM, Scboner RG. Enhanced translational efficiency with two-cistron expression system [ J ]. Methods Enzymol, 1990, 185: 94-103.

二级参考文献16

  • 1陈晓穗,汪保安,周丽君,王欲晓,曲佳,张达矜,王琰.热点突变法提高人源抗TNF-α抗体的亲和力[J].中华微生物学和免疫学杂志,2004,24(8):644-648. 被引量:2
  • 2刘向昕,展德文,张兆山.细菌表面展示技术的应用研究进展[J].微生物学免疫学进展,2005,33(2):70-74. 被引量:8
  • 3Wright A, Shin SU, Morrison SL. Genetically engineered antibodies: progress and prospects [ J ]. Crit Rev Immunol, 1992, 12 ( 3 - 4 ) : 125 - 168.
  • 4Pavlinkova G, Colcher D, Booth BJ, et al. Pharmacokinetics and bio-distribution of a light-chain-shuffled CCA9 single-chain Fv antibody construct[ J]. Cancer Immunol Immunother, 2000, 49 : 267 - 275.
  • 5Vasserot AP, Dickinson CD, Tang Y, et al. Optimization of protein therapeutics by directed evolution[ J]. Drug Discov Today, 2003 , 8 (3) : 118 -126.
  • 6Marks JD, Griffiths AD, Malmqvist M, et al. By-passing immuniza- tion: high affinity human antibodies by chain shuffling [ J ]. Biotech- nology (N Y) , 1992, 10(7) : 779 -783.
  • 7Yang WP, Green K, Pinz-Sweeney S, et al. CDR walking mutagene- sis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range [ J ]. J Mol Biol, 1995, 254 : 392 - 403.
  • 8Ho M, Kreitman R J, Onda M, et al. In vitro antibody evolution targe- ting germline hot spots to increase activity of an anti-CD22 immunotox- in [J]. J Biol Chem, 2005, 280(1) : 607 -617.
  • 9Saviranta P, Pajunen M, Janria P, et al. Engineering the steroid- specificity of an anti-17beta-estradiol Fab by random mutagenesis and competitive phage panning[J]. Protein Eng, 1998, 11 (2) : 143 - 152.
  • 10Prickett SR, Voskamp AL, Dacumos-HiU A, et al. Ara h 2 peptides containing dominant CD4 + T-cell epitopes: candidates for a peanut aUergy therapeutic [ J ]. J AUergy Clin Immunol, 2011, 127 ( 3 ) : 608-615. el-eS.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部